Ready to submit? Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window)

Journal overview

Please note that Clinical and Experimental Hypertension converted to a full Open Access journal from Volume 45 (2023). Previous volumes will continue to provide access through a Pay to Read model.

Aims & Scope

Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions.

Features special issues covering proceedings of symposia on hypertension research!

Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including

  • antihypertensive agents
  • circulatory control
  • drug development and application
  • etiology
  • mechanisms of action
  • neurogenic mechanisms
  • pathophysiology
  • pharmacological and nonpharmacological treatment
  • and much more!

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.

Read the Instructions for Authors for information on how to submit your article.

Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.

Read full aims and scope

Latest issues

Advertise in this journal

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Clinical and Experimental Hypertension.

Explore advertising options